PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Age shouldn't limit access to transplants for MDS, study suggests

2013-12-08
(Press-News.org) Contact information: Teresa Herbert
teresa_herbert@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute
Age shouldn't limit access to transplants for MDS, study suggests

NEW ORLEANS— Patients with myelodysplastic syndromes (MDS) who were as old as 74 fared as well with stem cell transplantation as did patients in the 60-to-65 age range, according to a study from Dana-Farber Cancer Institute presented at the annual meeting of the American Society of Hematology.

"This is good evidence that age alone should not limit who should get a transplant for MDS," said Gregory Abel, MD, MPH, a medical oncologist at Dana-Farber. "Calendar age is less important than other measures, such as whether a patient is physically fit enough to get through a transplant, has a lot of comorbidities, and what his or her performance status is."

MDS comprises several types of bone marrow failure causing severe anemia.

Abel, senior author Edwin P. Alyea, MD, and their colleagues analyzed the Dana-Farber experience over 10 years with reduced-intensity conditioning "mini-transplants" in patients with MDS, a group of bone-marrow disorders that generally develop in older adults. The mean age at diagnosis is 71.

Transplantation is the only potentially curative treatment for MDS in any age group, but many patients are not healthy enough to undergo the procedure.

The Dana-Farber researchers studied the records of 67 patients ranging in age from 60 to 74. The majority – 64 percent – received transplants from unrelated donors. Comparing recipients who were 60 to 65 with those older than 66, there were no statistically significant differences in overall survival at four years or in four-year survival without disease progression.

Patients in the two age groups also had comparable rates of deaths that weren't caused by disease relapse, and in the cumulative incidence of relapse itself. In addition, using significant components of the revised International Prognostic Scoring System (IPSS-R), the authors created a new risk score to predict four-year overall survival at time of transplantation. In two multivariable models, one that included the IPSS-R and another that included the new score, age was not a significant predictor of overall survival.

The study findings, said Abel, "are good news, since patients with MDS tend to be elderly and this is the only curative treatment at the moment for this disease."

"We hope this contributes to a growing body of evidence that treatment options should not be denied because of advanced age alone," said Alyea. "This is especially important in the older patients who have Medicare."



INFORMATION:



Dr. Abel's work was in part supported by a Scholar in Clinical Research Award from the Leukemia and Lymphoma Society.



ELSE PRESS RELEASES FROM THIS DATE:

Rare cause of anemia in newborns often overlooked, research suggests

2013-12-08
Rare cause of anemia in newborns often overlooked, research suggests Scientists recommend testing for Pearson syndrome in patients with congenital anemia Some babies diagnosed with and treated for a bone marrow failure disorder, called Diamond Blackfan ...

T cell immunotherapy: Promising results in children and adults with leukemia

2013-12-07
T cell immunotherapy: Promising results in children and adults with leukemia Researchers from The Children's Hospital of Philadelphia and University of Pennsylvania harness engineered T cells to eliminate tumors in blood Nearly 90 percent of ...

High-tech gene-therapy advances offer hope for patients with hard-to-treat blood disorders

2013-12-07
High-tech gene-therapy advances offer hope for patients with hard-to-treat blood disorders (NEW ORLEANS, December 7, 2013) – A series of advancements in genetically engineered cell therapies demonstrate early efficacy and safety in patients ...

Advances in stem cell transplantation strategies show promise to improve availability, success

2013-12-07
Advances in stem cell transplantation strategies show promise to improve availability, success (NEW ORLEANS, December 7, 2013) – Hematopoietic stem cell transplantation (HSCT), once considered an effective yet risky alternative to drug ...

International gene therapy trial for 'bubble boy' disease shows promising early results

2013-12-07
International gene therapy trial for 'bubble boy' disease shows promising early results 8 of 9 children treated doing well, according to data presented to American Society of Hematology (NEW ORLEANS, December 7, 2013) – Hematopoietic stem cell transplantation ...

Penn Medicine team reports on study of first 59 leukemia patients who received cell therapy

2013-12-07
Penn Medicine team reports on study of first 59 leukemia patients who received cell therapy Genetically modified cells produce long-term remissions, persist in patients' bodies for over 3 years NEW ORLEANS – Three and a half years after ...

Decreased diversity of bacteria microbiome in the gut is associated with risk of colorectal cancer

2013-12-07
Decreased diversity of bacteria microbiome in the gut is associated with risk of colorectal cancer Decreased diversity in the microbial community found in the human gut is associated with colorectal cancer, according to a new study published ...

Gut microbes may be a risk factor for colorectal cancer

2013-12-07
Gut microbes may be a risk factor for colorectal cancer Findings have potential implications for prevention and treatment of the second leading cause of cancer death in the US (New York City) December 6, 2013 -- ...

NIST calibration tools to encourage use of novel medical imaging technique

2013-12-07
NIST calibration tools to encourage use of novel medical imaging technique The National Institute of Standards and Technology (NIST) has developed prototype calibration tools for an experimental medical imaging technique that offers ...

Cancer-promoting protein is vital to safe division of tumor cells

2013-12-07
Cancer-promoting protein is vital to safe division of tumor cells PKM2 controls mitosis, saving cancer cells from death and promoting brain tumor growth HOUSTON – Researchers have caught a protein they previously implicated in a variety ...

LAST 30 PRESS RELEASES:

Gene therapy delivers lasting immune protection in children with rare disorder

New world record set for fastest human whole genome sequencing, representing significant step towards revolutionizing genomic care in the NICU

Shedding light on materials in the physical, biological sciences

Study finds emotional tweets by politicians don’t always win followers and can backfire with diverse audiences

Paul “Bear” Bryant Awards announce 2025 Coach of the Year Award watch list

$3 million National Institute on Aging grant will provide much-needed support to underserved dementia caregivers

Study links obesity-driven fatty acids to breast cancer, warns against high-fat diets like keto

Did lead limit brain and language development in Neanderthals and other extinct hominids?

New study reveals alarming mental health and substance use disparities among LGBTQ+ youth

U.K. food insecurity is associated with mental health conditions

At least eight bat species commute or forage over pig farms in Northern Italy

Ancient teeth reveal mammalian responses to climate change in Southeast Asia

Targeting young adults beginning university may be especially effective for encouraging pro-environmental behaviors

This robotic skin allows tiny robots to navigate complex, fragile environments

‘Metabots’ shapeshift from flat sheets into hundreds of structures

Starting university boosts recycling and greener travel, a University of Bath study finds

How cilia choreograph their “Mexican wave”, enabling marine creatures to swim

Why women's brains face higher risk: scientists pinpoint X-chromosome gene behind MS and Alzheimer's

Ancient lead exposure shaped evolution of human brain

How the uplift of East Africa shaped its ecosystems: Climate model simulations reveal Miocene landscape transformation

Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies

Research alert: Bacterial chatter slows wound healing

American Society of Anesthesiologists names Patrick Giam, M.D., FASA, new president

High-entropy alloy nanozyme ROS biocatalyst treating tendinopathy via up-regulation of PGAM5/FUNDC1/GPX4 pathway

SwRI’s Dr. Pablo Bueno named AIAA Associate Fellow

Astronomers detect radio signals from a black hole tearing apart a star – outside a galactic center

Locking carbon in trees and soils could help ‘stabilize climate for centuries’ – but only if combined with underground storage

New research shows a tiny, regenerative worm could change our understanding of healing

Australia’s rainforests first to switch from carbon sink to source

First-trimester mRNA COVID-19 vaccination and risk of major congenital anomalies

[Press-News.org] Age shouldn't limit access to transplants for MDS, study suggests